Tagged with M

Hong Kong At the Centre for Oncology and Immunology, a flagship of Hong Kong’s Health@InnoHK initiative, science converges across disciplines and continents. Under the leadership of Professor Tak Wah Mak, the Centre is advancing a new understanding of how immune responses are shaped, not only by tumours, but by the nervous system…

Hong Kong With Asia-Pacific poised to become a global force in cell and gene therapy, Xellera Therapeutics is positioning itself at the heart of this transformation. Led by CEO Camie Chan, the Hong Kong-based company is bridging critical infrastructure gaps by offering GMP-certified manufacturing, regulatory compliance aligned with global standards, and a…

Saudi Arabia Saudi Arabia’s pharmaceutical sector continues its impressive growth leadership within the region. With a 9.1 percent market growth in 2024 and a projected USD 11.6 billion in sales, the Kingdom now commands nearly a third of the entire MENA pharma market. But this story goes far beyond impressive numbers. Through…

Denmark Home to a score of pioneering biopharma players, Denmark has recognized its life sciences industry as a cornerstone of the economy. After forming a public-private partnership forum in 2021, the Danish Life Sciences Council (DLSC), the government laid out an ambitious strategy for the sector. The DLSC has now taken…

Puerto Rico At PMC, reinvention isn’t just a strategy—it’s our commitment to staying relevant, connected, and impactful in the lives of patients, professionals, and communities we serve.   Ivelisse Casillas, founder of PMC Health Group, formerly Pharmacon, leads a team of 20 in delivering integrated healthcare communications. The company, specialising in digital…

Switzerland Bairbre Hickie, General Manager at Takeda, discusses the company’s strategic priorities in Switzerland, focusing on its commitment to bringing innovative treatments to patients and its role in advancing the life sciences ecosystem. In this interview, Hickie explores Takeda’s approach to partnerships, its focus on rare diseases and oncology, and how…

Saudi Arabia As Saudi Arabia reshapes its healthcare sector, Japanese-headquartered medtech player Terumo is deepening its presence, moving beyond market expansion to integration, innovation, and local manufacturing. Elias El Zoughbi, Country Manager for Terumo in Saudi Arabia, is at the helm of this transformation. Navigating a landscape where global expertise meets national…

Puerto Rico We are not only facilitating compliance, we are helping to rebuild confidence in Puerto Rico as a destination for medical careers. In a healthcare system strained by regulatory inertia and an ageing clinical workforce, CredeMtia stands at a critical crossroads of technology, policy, and operational reform. President and CEO Salvador…

Mexico Mexico has a long history of public healthcare reforms that have fluctuated along with the changing tides of the country’s government. The latest is an ambitious plan for the Institute of Social Security and Services for State Workers (ISSSTE). Aimed at expanding the reach of public services, the scheme announced…

Switzerland Oliver Kuhn, CEO of Selectchemie, has had a diverse career spanning various sectors, starting in the financial industry before transitioning to healthcare. Under his leadership, Selectchemie has sharpened its strong focus on high-quality APIs, excipients, as well as own dossiers and finished-dose-formulations, setting itself apart through a tailored service that…

Germany After February’s snap election that brought Friedrich Merz to power, a coalition between his conservative CDU/CSU bloc and the centre-left SPD has outlined an agreement this month that will serve as the framework for the new German government’s healthcare agenda . While the accord presents broad healthcare reforms, the key…

Puerto Rico We’re not just building facilities—we’re building the future of medicine, where innovation is inclusive, access is equitable, and every breakthrough brings us closer to a healthier world. Biopharmaceutical innovation is advancing rapidly, yet inefficiencies in development and manufacturing continue to slow progress. OcyonBio, under the leadership of CEO Robert Salcedo,…